Study of Specimens Obtained During Epilepsy Surgery
NCT00025714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131
Last updated 2024-07-19
Summary
This study will collect brain tissue samples for research purposes from patients undergoing surgery to treat epilepsy. The standard surgical procedure for medically intractable epilepsy i.e., epilepsy that cannot be controlled with medicine requires removal of more brain tissue than is needed for diagnostic study. This extra tissue, which would otherwise be discarded, will be used for research purposes. In addition, a blood vessel in the scalp, called the superficial temporal artery, is also normally cut during surgery, and a piece of this vessel will be taken for research use.
Patients 4 years of age or older who undergo surgery for medically intractable epilepsy may be eligible for this study.
Brain tissue collected under this protocol will be used for studies of brain cells in other diseases and of serotonin receptors. Any remaining brain tissue will be frozen for use in future research. The superficial temporal artery will be used for comparison with carotid arteries (a neck artery that supplies the brain) from patients with blockage of this blood vessel.
Conditions
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Kareem A Zaghloul, M.D. · National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility
- Min Age
- 4 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-10-10
- Primary Completion
- 2019-10-31
- Completion
- 2019-10-31
Countries
- United States
Study Locations
More Related Trials
-
Early Surgical Intervention to Treat Epilepsy
NCT00040326 ·Status: COMPLETED ·Phase: PHASE3
-
Cortical Resections in Drug Resistant Epilepsy
NCT04553354 ·Status: UNKNOWN
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Human Epilepsy Project 3
NCT05374928 ·Status: ACTIVE_NOT_RECRUITING
-
Multimodal Study of the Human Brain Epilepsy Tissue
NCT06022055 ·Status: RECRUITING ·Phase: NA
-
Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy
NCT05019404 ·Status: UNKNOWN ·Phase: NA
-
P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
NCT00524134 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Brain Infusion of Muscimol to Treat Epilepsy
NCT00005925 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery
NCT00887861 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Medicine in the Treatment of Epilepsy
NCT05450822 ·Status: RECRUITING
-
Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy
NCT06321822 ·Status: RECRUITING ·Phase: NA
-
Gene Expression Changes of Brain Tissue in Human Temporal Lobe Epilepsy With Hippocampal Sclerosis
NCT04917939 ·Status: ACTIVE_NOT_RECRUITING
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
Energy Expenditure and Quality of Life in Epilepsy
NCT04546711 ·Status: WITHDRAWN
-
The Human Epilepsy Project
NCT02126774 ·Status: COMPLETED
-
Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy
NCT00986115 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
NCT01147003 ·Status: COMPLETED ·Phase: PHASE2
-
Seizure Prophylaxis in Patients With Glioma or Brain Metastasis
NCT03436433 ·Status: TERMINATED ·Phase: PHASE2
-
Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies
NCT06794606 ·Status: RECRUITING
-
Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody
NCT02695797 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda
NCT05698537 ·Status: COMPLETED
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion
NCT04529954 ·Status: TERMINATED ·Phase: PHASE1/PHASE2